Target intelligence / Profile preview

Novel HLA class I pseudogene fragment (ENSG00000229836)

Target
ENSG00000229836
Molecular classification
Other (Pseudogene)
01

Overview

ENSG00000229836, known as the “novel HLA class I pseudogene fragment,” is a human pseudogene fragment located in the major histocompatibility complex (MHC) Class I region. Pseudogenes in this region are non-functional remnants of previously active HLA class I-related genes, arising through gene duplications and subsequent mutations. This particular fragment shares sequence homology with the HLA class I family, which encompasses highly polymorphic molecules essential for antigen presentation in the immune system, but it lacks protein-coding potential or known physiological function. It does not encode a protein, is not considered a therapeutic target, and has no direct disease associations, biomarker value, or safety concerns. This pseudogene and others in the HLA class I region are studied primarily for evolutionary insight into the structure and diversification of the HLA gene family and do not participate in immune signaling or disease pathways.

Other names
GC06M031275
02

Mechanism of action

None (not a protein-coding or functional regulatory gene)

03

Biological functions

Other (non-coding, no known biological function; derived from HLA class I)
04

Disease associations

Other (no established role in disease as this is a pseudogene fragment)

Beyond the preview

Go deeper on Novel HLA class I pseudogene fragment (ENSG00000229836).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel HLA class I pseudogene fragment (ENSG00000229836).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call